Related references
Note: Only part of the references are listed.m6A-dependent upregulation of TRAF6 by METTL3 is associated with metastatic osteosarcoma
Jing Wang et al.
JOURNAL OF BONE ONCOLOGY (2022)
Analysis of the function and mechanism of DIRAS1 in osteosarcoma
Huan Liu et al.
TISSUE & CELL (2022)
METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells
Renbing Jiang et al.
CELL DEATH DISCOVERY (2022)
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
Qiang Wang et al.
GUT (2020)
Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
Jianhao Li et al.
FRONTIERS IN ONCOLOGY (2020)
FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling
Hao Huang et al.
CANCER RESEARCH (2020)
N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1
Chenliang Zhou et al.
EBIOMEDICINE (2020)
NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021
Margaret von Mehren et al.
Journal of the National Comprehensive Cancer Network (2020)
METTL14 Overexpression Promotes Osteosarcoma Cell Apoptosis and Slows Tumor Progression via Caspase 3 Activation
Ziwen Liu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The Critical Role of RNA m6A Methylation in Cancer
Qing Lan et al.
CANCER RESEARCH (2019)
Functions of RNA N6-methyladenosine modification in cancer progression
Bing Chen et al.
MOLECULAR BIOLOGY REPORTS (2019)
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
Maximilian Stahl et al.
LEUKEMIA & LYMPHOMA (2019)
m6A modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5
Yi Zhang et al.
MOLECULAR CANCER (2019)
The Biology of m6A RNA Methylation in Normal and Malignant Hematopoiesis
Ly P. Vu et al.
CANCER DISCOVERY (2019)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2
Mengnuo Chen et al.
HEPATOLOGY (2018)
Recognition of RNA N6- methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huilin Huang et al.
NATURE CELL BIOLOGY (2018)
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu et al.
NATURE CELL BIOLOGY (2018)
RNA m6A modification and its function in diseases
Jiyu Tong et al.
FRONTIERS OF MEDICINE (2018)
METTL14 Suppresses the Metastatic Potential of Hepatocellular Carcinoma by Modulating N6-Methyladenosine- Dependent Primary MicroRNA Processing
Jin-Zhao Ma et al.
HEPATOLOGY (2017)
Post-transcriptional gene regulation by mRNA modifications
Boxuan Simen Zhao et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Isaia Barbieri et al.
NATURE (2017)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
YTHDC1 mediates nuclear export of N6 - methyladenosine methylated mRNAs
Ian A. Roundtree et al.
ELIFE (2017)
RNA editing-dependent epitranscriptome diversity in cancer stem cells
Qingfei Jiang et al.
NATURE REVIEWS CANCER (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development
Rui Lu et al.
CANCER CELL (2016)
The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
Shuibin Lin et al.
MOLECULAR CELL (2016)
Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex
Xiang Wang et al.
NATURE (2016)
The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid-induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
M. Ying et al.
ONCOGENE (2016)
Bone cancer incidence by morphological subtype: a global assessment
Patricia C. Valery et al.
CANCER CAUSES & CONTROL (2015)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
Establishment of Four New Human Primary Cell Cultures from Chemo-Naive Italian Osteosarcoma Patients
Marcella Laschi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα
Lei Zhang et al.
CELL CYCLE (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells
Yang Wang et al.
NATURE CELL BIOLOGY (2014)
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Jianzhao Liu et al.
NATURE CHEMICAL BIOLOGY (2014)
The dynamic epitranscriptome: N6-methyladenosine and gene expression control
Kate D. Meyer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Valentina Gandin et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Translational biology of osteosarcoma
Maya Kansara et al.
NATURE REVIEWS CANCER (2014)
Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing
Dan Dominissini et al.
NATURE PROTOCOLS (2013)
Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma
Nicholas M. Bernthal et al.
CANCER (2012)
All Trans Retinoic Acid and Cancer
Siddikuzzaman et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
Retinoid-suppressed phosphorylation of RARα mediates the differentiation pathway of osteosarcoma cells
P. Luo et al.
ONCOGENE (2010)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases
Chang-ye Zou et al.
ACTA PHARMACOLOGICA SINICA (2008)
MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression
Magda A. Meester-Smoor et al.
CARCINOGENESIS (2008)
MNI overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML
Michael Heuser et al.
BLOOD (2007)
The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription
Khm van Wely et al.
ONCOGENE (2007)
MN1 overexpression is an important step in the development of inv(16) AML
C. Carella et al.
LEUKEMIA (2007)
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics
Michael Heuser et al.
BLOOD (2006)
Inhibitory effects of 22-oxa-calcitriol and all-trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo
EF Barroga et al.
RESEARCH IN VETERINARY SCIENCE (2000)
Share Paper
